In this issue:
Romosozumab for postmenopausal osteoporosis: 3 vs. 12 months
Surgical vs. conservative management in bilateral
adrenal tumours and cortisol excess: CV outcomes
Parathyroidectomy and diabetes risk in primary hyperparathyroidism
Modified-release hydrocortisone for restoring morning cortisol in adrenal insufficiency
Impact of smoking in Graves' disease, and on fracture risk
Nonvertebral fractures with zoledronate beyond >3 years
Belzutifan for advanced PPGL
Once-weekly lonapegsomatropin for adult growth hormone deficiency
Testosterone for male hypogonadism: online information vs. clinical guidelines
Please login below to download this issue (PDF)